StockNews.com Upgrades Fortress Biotech (NASDAQ:FBIO) to Hold

StockNews.com upgraded shares of Fortress Biotech (NASDAQ:FBIO – Free Report) from a sell rating to a hold rating in a research report report published on Thursday. Several other equities research analysts have also recently weighed in on FBIO. Roth Mkm restated a buy rating and issued a $10.00 price objective on shares of Fortress Biotech […]

Leave a Reply

Your email address will not be published.

Previous post Cadiz (NASDAQ:CDZI) Lifted to Sell at StockNews.com
Next post StockNews.com Initiates Coverage on Smart Powerr (NASDAQ:CREG)